CD3 Switch-DARPin: Preclinical proof-of-concept for T cell engager with enhanced function in solid tumors The Switch-DARPin ... described in the Risk Factors section of Molecular Partners’ Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback